GamaMabs Pharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers (NCT03799731) | GamaMabs Pharma | 2018-07-11 |
| First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers (NCT02978755) | GamaMabs Pharma | 2016-06-01 |
Track GamaMabs Pharma automatically
Every clearance here is in the API, with alerts when new ones post.